Clinical trial
An Open,Multicenter Clinic Trial of the Effectiveness,Safety and Pharmacokinetics in the Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Local Caspofungin
NCT03857399 is registered in ClinicalTrials.gov with Cttq as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open,Multicenter Clinic Trial of the Effectiveness,Safety and Pharmacokinetics in the Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Local Caspofungin
- Lead sponsor
- Cttq
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 17, 2018
- Completion date
- December 31, 2019
- Enrollment
- 32 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
fungal infection